IBDEI21A ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32461,1,4,0)
;;=4^H34.8122
;;^UTILITY(U,$J,358.3,32461,2)
;;=^5138481
;;^UTILITY(U,$J,358.3,32462,0)
;;=H35.013^^128^1661^40
;;^UTILITY(U,$J,358.3,32462,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32462,1,3,0)
;;=3^Changes in Retinal Vascular Appearance,OU
;;^UTILITY(U,$J,358.3,32462,1,4,0)
;;=4^H35.013
;;^UTILITY(U,$J,358.3,32462,2)
;;=^5005584
;;^UTILITY(U,$J,358.3,32463,0)
;;=H35.011^^128^1661^38
;;^UTILITY(U,$J,358.3,32463,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32463,1,3,0)
;;=3^Changes in Retinal Vascular Appearance,OD
;;^UTILITY(U,$J,358.3,32463,1,4,0)
;;=4^H35.011
;;^UTILITY(U,$J,358.3,32463,2)
;;=^5005582
;;^UTILITY(U,$J,358.3,32464,0)
;;=H35.012^^128^1661^39
;;^UTILITY(U,$J,358.3,32464,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32464,1,3,0)
;;=3^Changes in Retinal Vascular Appearance,OS
;;^UTILITY(U,$J,358.3,32464,1,4,0)
;;=4^H35.012
;;^UTILITY(U,$J,358.3,32464,2)
;;=^5005583
;;^UTILITY(U,$J,358.3,32465,0)
;;=H35.023^^128^1661^43
;;^UTILITY(U,$J,358.3,32465,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32465,1,3,0)
;;=3^Exudative Retinopathy,OU
;;^UTILITY(U,$J,358.3,32465,1,4,0)
;;=4^H35.023
;;^UTILITY(U,$J,358.3,32465,2)
;;=^5005588
;;^UTILITY(U,$J,358.3,32466,0)
;;=H35.021^^128^1661^41
;;^UTILITY(U,$J,358.3,32466,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32466,1,3,0)
;;=3^Exudative Retinopathy,OD
;;^UTILITY(U,$J,358.3,32466,1,4,0)
;;=4^H35.021
;;^UTILITY(U,$J,358.3,32466,2)
;;=^5005586
;;^UTILITY(U,$J,358.3,32467,0)
;;=H35.022^^128^1661^42
;;^UTILITY(U,$J,358.3,32467,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32467,1,3,0)
;;=3^Exudative Retinopathy,OS
;;^UTILITY(U,$J,358.3,32467,1,4,0)
;;=4^H35.022
;;^UTILITY(U,$J,358.3,32467,2)
;;=^5005587
;;^UTILITY(U,$J,358.3,32468,0)
;;=H35.09^^128^1661^37
;;^UTILITY(U,$J,358.3,32468,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32468,1,3,0)
;;=3^Intraretinal Microvascular Abnormalities,Other
;;^UTILITY(U,$J,358.3,32468,1,4,0)
;;=4^H35.09
;;^UTILITY(U,$J,358.3,32468,2)
;;=^268617
;;^UTILITY(U,$J,358.3,32469,0)
;;=H35.23^^128^1661^46
;;^UTILITY(U,$J,358.3,32469,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32469,1,3,0)
;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
;;^UTILITY(U,$J,358.3,32469,1,4,0)
;;=4^H35.23
;;^UTILITY(U,$J,358.3,32469,2)
;;=^5005645
;;^UTILITY(U,$J,358.3,32470,0)
;;=H35.21^^128^1661^44
;;^UTILITY(U,$J,358.3,32470,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32470,1,3,0)
;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
;;^UTILITY(U,$J,358.3,32470,1,4,0)
;;=4^H35.21
;;^UTILITY(U,$J,358.3,32470,2)
;;=^5005643
;;^UTILITY(U,$J,358.3,32471,0)
;;=H35.22^^128^1661^45
;;^UTILITY(U,$J,358.3,32471,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32471,1,3,0)
;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
;;^UTILITY(U,$J,358.3,32471,1,4,0)
;;=4^H35.22
;;^UTILITY(U,$J,358.3,32471,2)
;;=^5005644
;;^UTILITY(U,$J,358.3,32472,0)
;;=H35.043^^128^1661^30
;;^UTILITY(U,$J,358.3,32472,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32472,1,3,0)
;;=3^Retinal Micro-Aneurysms,Unspec,OU
;;^UTILITY(U,$J,358.3,32472,1,4,0)
;;=4^H35.043
;;^UTILITY(U,$J,358.3,32472,2)
;;=^5005596
;;^UTILITY(U,$J,358.3,32473,0)
;;=H35.041^^128^1661^28
;;^UTILITY(U,$J,358.3,32473,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32473,1,3,0)
;;=3^Retinal Micro-Aneurysms,Unspec,OD
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI21A 3780 printed Sep 23, 2025@19:55:50 Page 2
IBDEI21A ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32461,1,4,0)
+2 ;;=4^H34.8122
+3 ;;^UTILITY(U,$J,358.3,32461,2)
+4 ;;=^5138481
+5 ;;^UTILITY(U,$J,358.3,32462,0)
+6 ;;=H35.013^^128^1661^40
+7 ;;^UTILITY(U,$J,358.3,32462,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,32462,1,3,0)
+10 ;;=3^Changes in Retinal Vascular Appearance,OU
+11 ;;^UTILITY(U,$J,358.3,32462,1,4,0)
+12 ;;=4^H35.013
+13 ;;^UTILITY(U,$J,358.3,32462,2)
+14 ;;=^5005584
+15 ;;^UTILITY(U,$J,358.3,32463,0)
+16 ;;=H35.011^^128^1661^38
+17 ;;^UTILITY(U,$J,358.3,32463,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,32463,1,3,0)
+20 ;;=3^Changes in Retinal Vascular Appearance,OD
+21 ;;^UTILITY(U,$J,358.3,32463,1,4,0)
+22 ;;=4^H35.011
+23 ;;^UTILITY(U,$J,358.3,32463,2)
+24 ;;=^5005582
+25 ;;^UTILITY(U,$J,358.3,32464,0)
+26 ;;=H35.012^^128^1661^39
+27 ;;^UTILITY(U,$J,358.3,32464,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,32464,1,3,0)
+30 ;;=3^Changes in Retinal Vascular Appearance,OS
+31 ;;^UTILITY(U,$J,358.3,32464,1,4,0)
+32 ;;=4^H35.012
+33 ;;^UTILITY(U,$J,358.3,32464,2)
+34 ;;=^5005583
+35 ;;^UTILITY(U,$J,358.3,32465,0)
+36 ;;=H35.023^^128^1661^43
+37 ;;^UTILITY(U,$J,358.3,32465,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,32465,1,3,0)
+40 ;;=3^Exudative Retinopathy,OU
+41 ;;^UTILITY(U,$J,358.3,32465,1,4,0)
+42 ;;=4^H35.023
+43 ;;^UTILITY(U,$J,358.3,32465,2)
+44 ;;=^5005588
+45 ;;^UTILITY(U,$J,358.3,32466,0)
+46 ;;=H35.021^^128^1661^41
+47 ;;^UTILITY(U,$J,358.3,32466,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,32466,1,3,0)
+50 ;;=3^Exudative Retinopathy,OD
+51 ;;^UTILITY(U,$J,358.3,32466,1,4,0)
+52 ;;=4^H35.021
+53 ;;^UTILITY(U,$J,358.3,32466,2)
+54 ;;=^5005586
+55 ;;^UTILITY(U,$J,358.3,32467,0)
+56 ;;=H35.022^^128^1661^42
+57 ;;^UTILITY(U,$J,358.3,32467,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,32467,1,3,0)
+60 ;;=3^Exudative Retinopathy,OS
+61 ;;^UTILITY(U,$J,358.3,32467,1,4,0)
+62 ;;=4^H35.022
+63 ;;^UTILITY(U,$J,358.3,32467,2)
+64 ;;=^5005587
+65 ;;^UTILITY(U,$J,358.3,32468,0)
+66 ;;=H35.09^^128^1661^37
+67 ;;^UTILITY(U,$J,358.3,32468,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,32468,1,3,0)
+70 ;;=3^Intraretinal Microvascular Abnormalities,Other
+71 ;;^UTILITY(U,$J,358.3,32468,1,4,0)
+72 ;;=4^H35.09
+73 ;;^UTILITY(U,$J,358.3,32468,2)
+74 ;;=^268617
+75 ;;^UTILITY(U,$J,358.3,32469,0)
+76 ;;=H35.23^^128^1661^46
+77 ;;^UTILITY(U,$J,358.3,32469,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,32469,1,3,0)
+80 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
+81 ;;^UTILITY(U,$J,358.3,32469,1,4,0)
+82 ;;=4^H35.23
+83 ;;^UTILITY(U,$J,358.3,32469,2)
+84 ;;=^5005645
+85 ;;^UTILITY(U,$J,358.3,32470,0)
+86 ;;=H35.21^^128^1661^44
+87 ;;^UTILITY(U,$J,358.3,32470,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,32470,1,3,0)
+90 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
+91 ;;^UTILITY(U,$J,358.3,32470,1,4,0)
+92 ;;=4^H35.21
+93 ;;^UTILITY(U,$J,358.3,32470,2)
+94 ;;=^5005643
+95 ;;^UTILITY(U,$J,358.3,32471,0)
+96 ;;=H35.22^^128^1661^45
+97 ;;^UTILITY(U,$J,358.3,32471,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,32471,1,3,0)
+100 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
+101 ;;^UTILITY(U,$J,358.3,32471,1,4,0)
+102 ;;=4^H35.22
+103 ;;^UTILITY(U,$J,358.3,32471,2)
+104 ;;=^5005644
+105 ;;^UTILITY(U,$J,358.3,32472,0)
+106 ;;=H35.043^^128^1661^30
+107 ;;^UTILITY(U,$J,358.3,32472,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,32472,1,3,0)
+110 ;;=3^Retinal Micro-Aneurysms,Unspec,OU
+111 ;;^UTILITY(U,$J,358.3,32472,1,4,0)
+112 ;;=4^H35.043
+113 ;;^UTILITY(U,$J,358.3,32472,2)
+114 ;;=^5005596
+115 ;;^UTILITY(U,$J,358.3,32473,0)
+116 ;;=H35.041^^128^1661^28
+117 ;;^UTILITY(U,$J,358.3,32473,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,32473,1,3,0)
+120 ;;=3^Retinal Micro-Aneurysms,Unspec,OD
